Subgroup analysis showed that in the previous trastuzumab subgroup, the median PFS of the pyrotinib group was significantly better than that of the lapatinib group (18
Subgroup analysis showed that in the previous trastuzumab subgroup, the median PFS of the pyrotinib group was significantly better than…